Correction to: J Nanobiotechnol 20:34 (2022) https://doi.org/10.1186/s12951-021–01161-3
Following publication of the original article [1], the authors reported that Fig. 4C was incorrect. The corrected Fig. 4 and the figure caption are given below. The corrections do not affect the results and conclusions. All authors agree to these corrections and apologize for these errors.
As@ZIF-8 NPs inhibited the invasion, migration and EMT of sublethally heated cells in vitro. Wound healing assay of sublethally heated Hep3B (A) and SMMC7721 cells (B) after incubation with free ATO, As@ZIF-8 NPs and ZIF-8 NPs for 24 h. Scale bar, 800 µm. Representative images of the migration and invasion of sublethally heated Hep3B (C) and SMMC7721 cells (D) after the indicated treatment and the related quantitative analysis chart (E). Scale bar, 1000 µm. (F) Protein expression of EMT markers N-cadherin, vimentin and E-cadherin in Hep3B and SMMC7721 cells after the indicated treatment. (ns, no statistical difference; *, P < 0.05)
Reference
Chen X, Huang Y, Chen H, Chen Z, Chen J, Wang H, Li D, Su Z. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression. J Nanobiotechnol. 2022;20:34. https://doi.org/10.1186/s12951-021-01161-3.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Chen, X., Huang, Y., Chen, H. et al. Correction to: Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression. J Nanobiotechnol 20, 175 (2022). https://doi.org/10.1186/s12951-022-01386-w
Published:
DOI: https://doi.org/10.1186/s12951-022-01386-w